RBC Capital reiterates Nike stock rating on China headwinds By Investing.com

Nike reported Q3 fiscal 2026 revenue of $11.3B (flat reported, -3% CC) and EPS of $0.35 (vs BTIG est. $0.26); gross margin was 40.2% with a 5 ppt headwind from inventory removals. Management guided calendar 2026 revenue down low-single-digits and EPS flat through fiscal Q2 2027 — guidance implies ~25% downside to fiscal 2027 EPS vs Visible Alpha consensus; shares fell ~9% after-hours to $52.82, near the 52-week low of $50.95, and multiple brokers cut price targets while largely retaining buy/overweight stances.

Analysis

Nike’s deliberate inventory reset in Greater China creates an outsized knock-on effect across the midstream: cutbacks in sell‑in will depress order books at contract manufacturers and regional distributors over the next 2–4 quarters, magnifying margin pressure beyond Nike via lower factory utilization and potential pricing concessions. Retail partners that rely on Nike for rotation (e.g., national mall-based wholesalers) will face earnings volatility as replenishment is pulled forward into DTC — this raises the probability of earnings misses at those wholesalers in the next 3–9 months even if underlying end‑consumer demand stabilizes.

A true recovery requires two mechanical fixes: visible sell‑through to clear the “unhealthy” buckets and a reacceleration of sell‑in cadence to normalize factory demand; expect meaningful gross‑margin tailwind only after 6–12 months of sell‑through and another 6 months for normalized replenishment to restore supplier volumes. Catalysts that would materially reverse the current repricing are a faster China consumer rebound or a demonstrable shrinkage in branded inventory (clearance velocity improving >20% month-over-month), while downside tail risks include increased promotional intensity from regional competitors and a macro shock that lengthens inventory digestion to 12–18 months.

Consensus is too binary: the market is pricing near‑term operational risk as permanent brand impairment. That understates Nike’s ability to transfer learnings from its North America Win‑Now actions into other regions and categories, which would re‑leverage existing marketing and supply infrastructure with limited incremental capex. Given the high fixed‑cost base in sourcing and marketing, a 200–300bps margin recovery within 12–18 months would re-rate the stock materially even with modest revenue growth, making asymmetric option structures and pair trades the most efficient way to express a recovery view while funding downside protection.

Key Decisions for Investors

• Long NKE LEAPs: Buy NKE Jan 2028 calls (12–24 month horizon) sized as 1–2% of portfolio to capture a 25–40% recovery scenario; downside is limited to premium paid, upside asymmetric if margins re‑expand and China stabilizes.
• Pair trade (relative value): Long NKE equity or LEAPs / Short FL (Foot Locker) equity — 6–12 month horizon. Rationale: Nike’s DTC acceleration should structurally outperform wholesale‑dependent FL while FL bears near‑term order pull‑forward risk; target payoff: +30% on pair if Nike recovers while FL declines 15–25%; cap losses by sizing short to 0.5–1x notional of long risk.
• Defined‑risk option collar on NKE: Buy NKE stock and purchase a 6–9 month put at ~10% OTM, fund by selling a 6–9 month call ~15–20% OTM. Outcome: protects downside over the digestion window while allowing for meaningful upside participation if Win‑Now scales regionally.
• Rotation idea: Reduce consumer cyclicals exposure and redeploy 1–2% into high‑conviction AI infra names (SMCI, APP) over 3–9 months — flow dynamics and multiple expansion in tech could outperform consumer discretionary if macro jitters persist; treat as tactical reallocation rather than permanent shift.